Cargando…

Pain in autoimmune inflammatory myopathies: a scoping review

BACKGROUND: Pain is considered a priority for research by adult patients with autoimmune inflammatory myopathy (AIM) and their families. Our aim was to review the literature for studies reporting on pain in adult AIM and to summarise their findings. METHODS: A scoping review was conducted searching...

Descripción completa

Detalles Bibliográficos
Autores principales: Leclair, Valérie, Tsui, Harmony, Hudson, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843184/
https://www.ncbi.nlm.nih.gov/pubmed/36635001
http://dx.doi.org/10.1136/rmdopen-2022-002591
_version_ 1784870330448216064
author Leclair, Valérie
Tsui, Harmony
Hudson, Marie
author_facet Leclair, Valérie
Tsui, Harmony
Hudson, Marie
author_sort Leclair, Valérie
collection PubMed
description BACKGROUND: Pain is considered a priority for research by adult patients with autoimmune inflammatory myopathy (AIM) and their families. Our aim was to review the literature for studies reporting on pain in adult AIM and to summarise their findings. METHODS: A scoping review was conducted searching for studies in PubMed and MEDLINE including more than five adult patients with AIM and assessing pain using a patient-reported outcome measure. Study population characteristics, pain measurement and clinical correlates of pain were extracted using a standardised protocol. RESULTS: The search strategy identified 2831 studies with 33 meeting inclusion criteria. Most studies used visual analogue scales (n=14) and/or the Medical Outcomes Study 36-Item Short Form Bodily Pain Scale (n=17). Frequency of pain and/or myalgias ranged from 64% to 100%. Subjects with AIM had significantly more pain than the general population and comparable pain to other chronic rheumatic diseases. Insufficient results were available to identify significant clinical correlates of pain in AIM. CONCLUSION: This review suggests that the burden of pain in AIM is considerable. Still, due to the heterogeneity and low quality of the evidence, significant knowledge gaps persist. Studies are needed to characterise pain trajectories of patients with AIM.
format Online
Article
Text
id pubmed-9843184
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-98431842023-01-18 Pain in autoimmune inflammatory myopathies: a scoping review Leclair, Valérie Tsui, Harmony Hudson, Marie RMD Open Pain BACKGROUND: Pain is considered a priority for research by adult patients with autoimmune inflammatory myopathy (AIM) and their families. Our aim was to review the literature for studies reporting on pain in adult AIM and to summarise their findings. METHODS: A scoping review was conducted searching for studies in PubMed and MEDLINE including more than five adult patients with AIM and assessing pain using a patient-reported outcome measure. Study population characteristics, pain measurement and clinical correlates of pain were extracted using a standardised protocol. RESULTS: The search strategy identified 2831 studies with 33 meeting inclusion criteria. Most studies used visual analogue scales (n=14) and/or the Medical Outcomes Study 36-Item Short Form Bodily Pain Scale (n=17). Frequency of pain and/or myalgias ranged from 64% to 100%. Subjects with AIM had significantly more pain than the general population and comparable pain to other chronic rheumatic diseases. Insufficient results were available to identify significant clinical correlates of pain in AIM. CONCLUSION: This review suggests that the burden of pain in AIM is considerable. Still, due to the heterogeneity and low quality of the evidence, significant knowledge gaps persist. Studies are needed to characterise pain trajectories of patients with AIM. BMJ Publishing Group 2023-01-12 /pmc/articles/PMC9843184/ /pubmed/36635001 http://dx.doi.org/10.1136/rmdopen-2022-002591 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Pain
Leclair, Valérie
Tsui, Harmony
Hudson, Marie
Pain in autoimmune inflammatory myopathies: a scoping review
title Pain in autoimmune inflammatory myopathies: a scoping review
title_full Pain in autoimmune inflammatory myopathies: a scoping review
title_fullStr Pain in autoimmune inflammatory myopathies: a scoping review
title_full_unstemmed Pain in autoimmune inflammatory myopathies: a scoping review
title_short Pain in autoimmune inflammatory myopathies: a scoping review
title_sort pain in autoimmune inflammatory myopathies: a scoping review
topic Pain
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843184/
https://www.ncbi.nlm.nih.gov/pubmed/36635001
http://dx.doi.org/10.1136/rmdopen-2022-002591
work_keys_str_mv AT leclairvalerie paininautoimmuneinflammatorymyopathiesascopingreview
AT tsuiharmony paininautoimmuneinflammatorymyopathiesascopingreview
AT hudsonmarie paininautoimmuneinflammatorymyopathiesascopingreview